Oramed Pharmaceuticals logo

Oramed Pharmaceuticals share price today

(ORMP)

Oramed Pharmaceuticals share price is $2.36 & ₹201.24 as on 27 Dec 2024, 2.30 'hrs' IST

$2.36

-0.02

(-0.84%)

Market is closed - opens 8 PM, 27 Dec 2024

View live Oramed Pharmaceuticals share price in Dollar and Rupees. Guide to invest in Oramed Pharmaceuticals from India. Also see the sentimental analysis on Indian investors investing in Oramed Pharmaceuticals. Get details on the Indian mutual funds that are investing in Oramed Pharmaceuticals. Get Analyst recommendations and forecasts along with all the Oramed Pharmaceuticals's financials.

Oramed Pharmaceuticals share price movements

  • Today's Low: $2.35
    Today's High: $2.38

    Day's Volatility :1.47%

  • 52 Weeks Low: $2.00
    52 Weeks High: $3.67

    52 Weeks Volatility :45.5%

Oramed Pharmaceuticals Returns

PeriodOramed Pharmaceuticals IncSector (Health Care)Index (Russel 2000)
3 Months
-4.03%
-9.0%
0.0%
6 Months
-7.39%
-4.6%
0.0%
1 Year
1.71%
3.0%
0.0%
3 Years
-81.66%
0.0%
-21.1%

Oramed Pharmaceuticals Key Statistics

in dollars & INR

Previous Close
$2.38
Open
$2.35
Today's High
$2.38
Today's Low
$2.345
Market Capitalization
$94.6M
Today's Volume
$61.6K
52 Week High
$3.67
52 Week Low
$2.0
Revenue TTM
$0.0
EBITDA
$-12.8M
Earnings Per Share (EPS)
$0.51
PE Ratio
4.55
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
2.89%

How to invest in Oramed Pharmaceuticals from India?

It is very easy for Indian residents to invest directly in Oramed Pharmaceuticals from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Oramed Pharmaceuticals stock in both Indian Rupees (INR) and US Dollars (USD). Search for Oramed Pharmaceuticals or ORMP on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Oramed Pharmaceuticals or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Oramed Pharmaceuticals shares which would translate to 0.361 fractional shares of Oramed Pharmaceuticals as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Oramed Pharmaceuticals, in just a few clicks!

Returns in Oramed Pharmaceuticals for Indian investors in Rupees

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Oramed Pharmaceuticals investment value today

Current value as on today

₹1,03,180

Returns

₹3,180

(+3.18%)

Returns from Oramed Pharmaceuticals Stock

₹855 (+0.85%)

Dollar Returns

₹2,325 (+2.33%)

Indian investors sentiment towards Oramed Pharmaceuticals

-31%

Period: Sep 27, 2024 to Dec 26, 2024. Change in 30 Days versus previous period

Search volume for Oramed Pharmaceuticals on INDmoney from India has reduced in the last 30 days as on Dec 27, 2024. -31% less investors are searching Oramed Pharmaceuticals in the last 30 days versus the previous period.

Global Institutional Holdings in Oramed Pharmaceuticals

  • BML Capital Management LLC

    5.42%

  • Murchinson Ltd.

    4.24%

  • BOOTHBAY FUND MANAGEMENT, LLC

    2.05%

  • Rathbone Brothers PLC

    0.72%

  • Two Sigma Advisers, LLC

    0.63%

  • Renaissance Technologies Corp

    0.61%

Analyst Recommendation on Oramed Pharmaceuticals

Hold

    0%Buy

    57%Hold

    42%Sell

Based on 7 Wall street analysts offering stock ratings for Oramed Pharmaceuticals(by analysts ranked 0 to 5 stars)

Based on 7 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
0
0
0
Hold
4
4
4
Sell
3
3
3

Analyst Forecast on Oramed Pharmaceuticals

What analysts predicted

Upside of 37.71%

Current:

$2.36

Target:

$3.25

Insights on Oramed Pharmaceuticals

  • Price Movement

    In the last 7 days, ORMP stock has moved down by -4.4%
  • Increasing Revenue

    Revenue is up for the last 3 quarters, 666.0K → 674.0K (in $), with an average increase of 0.6% per quarter
  • Decreasing Net Profit

    Netprofit is down for the last 2 quarters, 9.21M → -19.61M (in $), with an average decrease of 313.0% per quarter
  • ORMP vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 27.2% return, outperforming this stock by 17.0%
  • ORMP vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 25.2% return, outperforming this stock by 109.9%

Oramed Pharmaceuticals Technicals Summary

Sell

Neutral

Buy

Oramed Pharmaceuticals is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Oramed Pharmaceuticals Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Oramed Pharmaceuticals Inc
0.42%
-7.39%
1.71%
-81.66%
-79.61%
Regeneron Pharmaceuticals, Inc.
-5.12%
-32.02%
-18.97%
11.91%
91.19%
Biontech Se
-3.72%
42.02%
7.95%
-52.72%
226.93%
Alnylam Pharmaceuticals, Inc.
-3.99%
0.1%
24.29%
44.19%
112.09%
Vertex Pharmaceuticals Incorporated
-12.61%
-12.92%
-0.27%
83.92%
86.41%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Oramed Pharmaceuticals Inc
4.55
4.55
0.0
0.24
0.03
-0.04
NA
3.89
Regeneron Pharmaceuticals, Inc.
17.67
17.67
1.06
45.07
0.17
0.07
NA
272.04
Biontech Se
160.8
NA
0.04
-3.11
-0.02
-0.01
NA
79.73
Alnylam Pharmaceuticals, Inc.
NA
NA
-0.49
-0.19
-15.01
-0.03
NA
0.25
Vertex Pharmaceuticals Incorporated
32.84
NA
1.06
0.51
-0.03
0.12
NA
60.65
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Oramed Pharmaceuticals Inc
Hold
$94.6M
-79.61%
4.55
0.0%
Regeneron Pharmaceuticals, Inc.
Buy
$78.5B
91.19%
17.67
33.61%
Biontech Se
Buy
$27.4B
226.93%
160.8
-15.36%
Alnylam Pharmaceuticals, Inc.
Buy
$31.4B
112.09%
NA
-15.86%
Vertex Pharmaceuticals Incorporated
Buy
$105.1B
86.41%
32.84
-4.51%

About Oramed Pharmaceuticals

oramed pharmaceuticals (nasdaqcm:ormp) is developing proprietary technology for the oral delivery of drugs presently administered by way of injection. through its patented flagship product, an orally ingestible insulin capsule currently in phase 2 trials under the usfda, the company is seeking to revolutionize the treatment of diabetes. read more: http://www.oramed.com/investors/corporate-presentation watch: https://www.youtube.com/watch?v=5qchxtdv9eg
Organization
Oramed Pharmaceuticals
Employees
0
CEO
Mr. Nadav Kidron Esq.
Industry
Health Technology

Management People of Oramed Pharmaceuticals

NameTitle
Mr. Nadav Kidron Esq.
President, CEO & Executive Chairman
Dr. Miriam Kidron Ph.D.
Chief Scientific Officer & Director
Mr. Avraham Gabay
CFO, Treasurer & Secretary
Mr. Joshua Hexter
Chief Operating & Business Officer

Important FAQs about investing in Oramed Pharmaceuticals from India :

What is Oramed Pharmaceuticals share price today?

Oramed Pharmaceuticals share price today stands at $2.36, Open: $2.35 ; Previous Close: $2.38 ; High: $2.38 ; Low: $2.35 ; 52 Week High: $3.67 ; 52 Week Low: $2.00. The stock opens at $2.35, after a previous close of $2.38. The stock reached a daily high of $2.38 and a low of $2.35, with a 52-week high of $3.67 and a 52-week low of $2.00.

Can Indians buy Oramed Pharmaceuticals shares?

Yes, Indians can invest in the Oramed Pharmaceuticals (ORMP) from India.

With INDmoney, you can buy Oramed Pharmaceuticals at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Oramed Pharmaceuticals at zero transaction cost.

How can I buy Oramed Pharmaceuticals shares from India?

It is very easy to buy Oramed Pharmaceuticals from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Oramed Pharmaceuticals be purchased?

Yes, you can buy fractional shares of Oramed Pharmaceuticals with INDmoney app.

What are the documents required to start investing in Oramed Pharmaceuticals stocks?

To start investing in Oramed Pharmaceuticals, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Oramed Pharmaceuticals

Today’s highest price of Oramed Pharmaceuticals (ORMP) is $2.38.

Today’s lowest price of Oramed Pharmaceuticals (ORMP) is $2.35.

What is today's market capitalisation of Oramed Pharmaceuticals

Today's market capitalisation of Oramed Pharmaceuticals ORMP is 94.6M

What is the 52 Week High and Low Range of Oramed Pharmaceuticals

  • 52 Week High

    $3.67

  • 52 Week Low

    $2.00

What are the historical returns of Oramed Pharmaceuticals?

  • 1 Month Returns

    0.42%

  • 3 Months Returns

    -7.39%

  • 1 Year Returns

    1.71%

  • 5 Years Returns

    -79.61%

Who is the Chief Executive Officer (CEO) of Oramed Pharmaceuticals

Mr. Nadav Kidron Esq. is the current Chief Executive Officer (CEO) of Oramed Pharmaceuticals.